COVID-19 Impact on Global Osimertinib Market Insights, Forecast to 2026
![](/report_cover/6975/covid-19-impact-on-global-osimertinib-market-insights-forecast-to-2026_en.gif)
Osimertinib market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Osimertinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Osimertinib market is segmented into
The Osimertinib market is analysed and market size information is provided by regions (countries).
The key regions covered in the Osimertinib market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Osimertinib Market Share Analysis
Osimertinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Osimertinib business, the date to enter into the Osimertinib market, Osimertinib product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Osimertinib market is segmented into
- 40mg*30 Tablets
- 80mg*30 Tablets
- 40mg*10 Tablets
- 80mg*10 Tablets
- Locally Advanced NSCLC
- Metastatic NSCLC
- Other
The Osimertinib market is analysed and market size information is provided by regions (countries).
The key regions covered in the Osimertinib market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Osimertinib Market Share Analysis
Osimertinib market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Osimertinib business, the date to enter into the Osimertinib market, Osimertinib product introduction, recent developments, etc.
The major vendors covered:
- AstraZeneca
- Incepta Pharmaceuticals Limited
- Everest Pharmaceuticals
- Beacon Pharma
- Drug International
1 STUDY COVERAGE
1.1 Osimertinib Product Introduction
1.2 Market Segments
1.3 Key Osimertinib Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Osimertinib Market Size Growth Rate by Type
1.4.2 40mg*30 Tablets
1.4.3 80mg*30 Tablets
1.4.4 40mg*10 Tablets
1.4.5 80mg*10 Tablets
1.5 Market by Application
1.5.1 Global Osimertinib Market Size Growth Rate by Application
1.5.2 Locally Advanced NSCLC
1.5.3 Metastatic NSCLC
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Osimertinib Industry Impact
1.6.1 How the Covid-19 is Affecting the Osimertinib Industry
1.6.1.1 Osimertinib Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Osimertinib Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Osimertinib Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Osimertinib Market Size Estimates and Forecasts
2.1.1 Global Osimertinib Revenue 2015-2026
2.1.2 Global Osimertinib Sales 2015-2026
2.2 Osimertinib Market Size by Region: 2020 Versus 2026
2.2.1 Global Osimertinib Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Osimertinib Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OSIMERTINIB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Osimertinib Sales by Manufacturers
3.1.1 Osimertinib Sales by Manufacturers (2015-2020)
3.1.2 Osimertinib Sales Market Share by Manufacturers (2015-2020)
3.2 Osimertinib Revenue by Manufacturers
3.2.1 Osimertinib Revenue by Manufacturers (2015-2020)
3.2.2 Osimertinib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Osimertinib Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Osimertinib Revenue in 2019
3.2.5 Global Osimertinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Osimertinib Price by Manufacturers
3.4 Osimertinib Manufacturing Base Distribution, Product Types
3.4.1 Osimertinib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Osimertinib Product Type
3.4.3 Date of International Manufacturers Enter into Osimertinib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Osimertinib Market Size by Type (2015-2020)
4.1.1 Global Osimertinib Sales by Type (2015-2020)
4.1.2 Global Osimertinib Revenue by Type (2015-2020)
4.1.3 Osimertinib Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Osimertinib Market Size Forecast by Type (2021-2026)
4.2.1 Global Osimertinib Sales Forecast by Type (2021-2026)
4.2.2 Global Osimertinib Revenue Forecast by Type (2021-2026)
4.2.3 Osimertinib Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Osimertinib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Osimertinib Market Size by Application (2015-2020)
5.1.1 Global Osimertinib Sales by Application (2015-2020)
5.1.2 Global Osimertinib Revenue by Application (2015-2020)
5.1.3 Osimertinib Price by Application (2015-2020)
5.2 Osimertinib Market Size Forecast by Application (2021-2026)
5.2.1 Global Osimertinib Sales Forecast by Application (2021-2026)
5.2.2 Global Osimertinib Revenue Forecast by Application (2021-2026)
5.2.3 Global Osimertinib Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Osimertinib by Country
6.1.1 North America Osimertinib Sales by Country
6.1.2 North America Osimertinib Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Osimertinib Market Facts & Figures by Type
6.3 North America Osimertinib Market Facts & Figures by Application
7 EUROPE
7.1 Europe Osimertinib by Country
7.1.1 Europe Osimertinib Sales by Country
7.1.2 Europe Osimertinib Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Osimertinib Market Facts & Figures by Type
7.3 Europe Osimertinib Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Osimertinib by Region
8.1.1 Asia Pacific Osimertinib Sales by Region
8.1.2 Asia Pacific Osimertinib Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Osimertinib Market Facts & Figures by Type
8.3 Asia Pacific Osimertinib Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Osimertinib by Country
9.1.1 Latin America Osimertinib Sales by Country
9.1.2 Latin America Osimertinib Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Osimertinib Market Facts & Figures by Type
9.3 Central & South America Osimertinib Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Osimertinib by Country
10.1.1 Middle East and Africa Osimertinib Sales by Country
10.1.2 Middle East and Africa Osimertinib Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Osimertinib Market Facts & Figures by Type
10.3 Middle East and Africa Osimertinib Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Osimertinib Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Incepta Pharmaceuticals Limited
11.2.1 Incepta Pharmaceuticals Limited Corporation Information
11.2.2 Incepta Pharmaceuticals Limited Description, Business Overview and Total Revenue
11.2.3 Incepta Pharmaceuticals Limited Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Incepta Pharmaceuticals Limited Osimertinib Products Offered
11.2.5 Incepta Pharmaceuticals Limited Recent Development
11.3 Everest Pharmaceuticals
11.3.1 Everest Pharmaceuticals Corporation Information
11.3.2 Everest Pharmaceuticals Description, Business Overview and Total Revenue
11.3.3 Everest Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Everest Pharmaceuticals Osimertinib Products Offered
11.3.5 Everest Pharmaceuticals Recent Development
11.4 Beacon Pharma
11.4.1 Beacon Pharma Corporation Information
11.4.2 Beacon Pharma Description, Business Overview and Total Revenue
11.4.3 Beacon Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Beacon Pharma Osimertinib Products Offered
11.4.5 Beacon Pharma Recent Development
11.5 Drug International
11.5.1 Drug International Corporation Information
11.5.2 Drug International Description, Business Overview and Total Revenue
11.5.3 Drug International Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Drug International Osimertinib Products Offered
11.5.5 Drug International Recent Development
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Osimertinib Products Offered
11.1.5 AstraZeneca Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Osimertinib Market Estimates and Projections by Region
12.1.1 Global Osimertinib Sales Forecast by Regions 2021-2026
12.1.2 Global Osimertinib Revenue Forecast by Regions 2021-2026
12.2 North America Osimertinib Market Size Forecast (2021-2026)
12.2.1 North America: Osimertinib Sales Forecast (2021-2026)
12.2.2 North America: Osimertinib Revenue Forecast (2021-2026)
12.2.3 North America: Osimertinib Market Size Forecast by Country (2021-2026)
12.3 Europe Osimertinib Market Size Forecast (2021-2026)
12.3.1 Europe: Osimertinib Sales Forecast (2021-2026)
12.3.2 Europe: Osimertinib Revenue Forecast (2021-2026)
12.3.3 Europe: Osimertinib Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Osimertinib Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Osimertinib Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Osimertinib Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Osimertinib Market Size Forecast by Region (2021-2026)
12.5 Latin America Osimertinib Market Size Forecast (2021-2026)
12.5.1 Latin America: Osimertinib Sales Forecast (2021-2026)
12.5.2 Latin America: Osimertinib Revenue Forecast (2021-2026)
12.5.3 Latin America: Osimertinib Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Osimertinib Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Osimertinib Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Osimertinib Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Osimertinib Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Osimertinib Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Osimertinib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Osimertinib Product Introduction
1.2 Market Segments
1.3 Key Osimertinib Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Osimertinib Market Size Growth Rate by Type
1.4.2 40mg*30 Tablets
1.4.3 80mg*30 Tablets
1.4.4 40mg*10 Tablets
1.4.5 80mg*10 Tablets
1.5 Market by Application
1.5.1 Global Osimertinib Market Size Growth Rate by Application
1.5.2 Locally Advanced NSCLC
1.5.3 Metastatic NSCLC
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Osimertinib Industry Impact
1.6.1 How the Covid-19 is Affecting the Osimertinib Industry
1.6.1.1 Osimertinib Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Osimertinib Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Osimertinib Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Osimertinib Market Size Estimates and Forecasts
2.1.1 Global Osimertinib Revenue 2015-2026
2.1.2 Global Osimertinib Sales 2015-2026
2.2 Osimertinib Market Size by Region: 2020 Versus 2026
2.2.1 Global Osimertinib Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Osimertinib Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL OSIMERTINIB COMPETITOR LANDSCAPE BY PLAYERS
3.1 Osimertinib Sales by Manufacturers
3.1.1 Osimertinib Sales by Manufacturers (2015-2020)
3.1.2 Osimertinib Sales Market Share by Manufacturers (2015-2020)
3.2 Osimertinib Revenue by Manufacturers
3.2.1 Osimertinib Revenue by Manufacturers (2015-2020)
3.2.2 Osimertinib Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Osimertinib Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Osimertinib Revenue in 2019
3.2.5 Global Osimertinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Osimertinib Price by Manufacturers
3.4 Osimertinib Manufacturing Base Distribution, Product Types
3.4.1 Osimertinib Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Osimertinib Product Type
3.4.3 Date of International Manufacturers Enter into Osimertinib Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Osimertinib Market Size by Type (2015-2020)
4.1.1 Global Osimertinib Sales by Type (2015-2020)
4.1.2 Global Osimertinib Revenue by Type (2015-2020)
4.1.3 Osimertinib Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Osimertinib Market Size Forecast by Type (2021-2026)
4.2.1 Global Osimertinib Sales Forecast by Type (2021-2026)
4.2.2 Global Osimertinib Revenue Forecast by Type (2021-2026)
4.2.3 Osimertinib Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Osimertinib Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Osimertinib Market Size by Application (2015-2020)
5.1.1 Global Osimertinib Sales by Application (2015-2020)
5.1.2 Global Osimertinib Revenue by Application (2015-2020)
5.1.3 Osimertinib Price by Application (2015-2020)
5.2 Osimertinib Market Size Forecast by Application (2021-2026)
5.2.1 Global Osimertinib Sales Forecast by Application (2021-2026)
5.2.2 Global Osimertinib Revenue Forecast by Application (2021-2026)
5.2.3 Global Osimertinib Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Osimertinib by Country
6.1.1 North America Osimertinib Sales by Country
6.1.2 North America Osimertinib Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Osimertinib Market Facts & Figures by Type
6.3 North America Osimertinib Market Facts & Figures by Application
7 EUROPE
7.1 Europe Osimertinib by Country
7.1.1 Europe Osimertinib Sales by Country
7.1.2 Europe Osimertinib Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Osimertinib Market Facts & Figures by Type
7.3 Europe Osimertinib Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Osimertinib by Region
8.1.1 Asia Pacific Osimertinib Sales by Region
8.1.2 Asia Pacific Osimertinib Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Osimertinib Market Facts & Figures by Type
8.3 Asia Pacific Osimertinib Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Osimertinib by Country
9.1.1 Latin America Osimertinib Sales by Country
9.1.2 Latin America Osimertinib Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Osimertinib Market Facts & Figures by Type
9.3 Central & South America Osimertinib Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Osimertinib by Country
10.1.1 Middle East and Africa Osimertinib Sales by Country
10.1.2 Middle East and Africa Osimertinib Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Osimertinib Market Facts & Figures by Type
10.3 Middle East and Africa Osimertinib Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Osimertinib Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Incepta Pharmaceuticals Limited
11.2.1 Incepta Pharmaceuticals Limited Corporation Information
11.2.2 Incepta Pharmaceuticals Limited Description, Business Overview and Total Revenue
11.2.3 Incepta Pharmaceuticals Limited Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Incepta Pharmaceuticals Limited Osimertinib Products Offered
11.2.5 Incepta Pharmaceuticals Limited Recent Development
11.3 Everest Pharmaceuticals
11.3.1 Everest Pharmaceuticals Corporation Information
11.3.2 Everest Pharmaceuticals Description, Business Overview and Total Revenue
11.3.3 Everest Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Everest Pharmaceuticals Osimertinib Products Offered
11.3.5 Everest Pharmaceuticals Recent Development
11.4 Beacon Pharma
11.4.1 Beacon Pharma Corporation Information
11.4.2 Beacon Pharma Description, Business Overview and Total Revenue
11.4.3 Beacon Pharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Beacon Pharma Osimertinib Products Offered
11.4.5 Beacon Pharma Recent Development
11.5 Drug International
11.5.1 Drug International Corporation Information
11.5.2 Drug International Description, Business Overview and Total Revenue
11.5.3 Drug International Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Drug International Osimertinib Products Offered
11.5.5 Drug International Recent Development
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Description, Business Overview and Total Revenue
11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AstraZeneca Osimertinib Products Offered
11.1.5 AstraZeneca Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Osimertinib Market Estimates and Projections by Region
12.1.1 Global Osimertinib Sales Forecast by Regions 2021-2026
12.1.2 Global Osimertinib Revenue Forecast by Regions 2021-2026
12.2 North America Osimertinib Market Size Forecast (2021-2026)
12.2.1 North America: Osimertinib Sales Forecast (2021-2026)
12.2.2 North America: Osimertinib Revenue Forecast (2021-2026)
12.2.3 North America: Osimertinib Market Size Forecast by Country (2021-2026)
12.3 Europe Osimertinib Market Size Forecast (2021-2026)
12.3.1 Europe: Osimertinib Sales Forecast (2021-2026)
12.3.2 Europe: Osimertinib Revenue Forecast (2021-2026)
12.3.3 Europe: Osimertinib Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Osimertinib Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Osimertinib Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Osimertinib Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Osimertinib Market Size Forecast by Region (2021-2026)
12.5 Latin America Osimertinib Market Size Forecast (2021-2026)
12.5.1 Latin America: Osimertinib Sales Forecast (2021-2026)
12.5.2 Latin America: Osimertinib Revenue Forecast (2021-2026)
12.5.3 Latin America: Osimertinib Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Osimertinib Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Osimertinib Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Osimertinib Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Osimertinib Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Osimertinib Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Osimertinib Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Osimertinib Market Segments
Table 2. Ranking of Global Top Osimertinib Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Osimertinib Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 40mg*30 Tablets
Table 5. Major Manufacturers of 80mg*30 Tablets
Table 6. Major Manufacturers of 40mg*10 Tablets
Table 7. Major Manufacturers of 80mg*10 Tablets
Table 8. COVID-19 Impact Global Market: (Four Osimertinib Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Osimertinib Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Osimertinib Players to Combat Covid-19 Impact
Table 13. Global Osimertinib Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 14. Global Osimertinib Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 15. Global Osimertinib Sales by Regions 2015-2020 (K Pcs)
Table 16. Global Osimertinib Sales Market Share by Regions (2015-2020)
Table 17. Global Osimertinib Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Osimertinib Sales by Manufacturers (2015-2020) (K Pcs)
Table 19. Global Osimertinib Sales Share by Manufacturers (2015-2020)
Table 20. Global Osimertinib Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Osimertinib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osimertinib as of 2019)
Table 22. Osimertinib Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Osimertinib Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Osimertinib Price (2015-2020) (USD/Pcs)
Table 25. Osimertinib Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Osimertinib Product Type
Table 27. Date of International Manufacturers Enter into Osimertinib Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 30. Global Osimertinib Sales Share by Type (2015-2020)
Table 31. Global Osimertinib Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Osimertinib Revenue Share by Type (2015-2020)
Table 33. Osimertinib Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 34. Global Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 35. Global Osimertinib Sales Share by Application (2015-2020)
Table 36. North America Osimertinib Sales by Country (2015-2020) (K Pcs)
Table 37. North America Osimertinib Sales Market Share by Country (2015-2020)
Table 38. North America Osimertinib Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Osimertinib Revenue Market Share by Country (2015-2020)
Table 40. North America Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 41. North America Osimertinib Sales Market Share by Type (2015-2020)
Table 42. North America Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 43. North America Osimertinib Sales Market Share by Application (2015-2020)
Table 44. Europe Osimertinib Sales by Country (2015-2020) (K Pcs)
Table 45. Europe Osimertinib Sales Market Share by Country (2015-2020)
Table 46. Europe Osimertinib Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Osimertinib Revenue Market Share by Country (2015-2020)
Table 48. Europe Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 49. Europe Osimertinib Sales Market Share by Type (2015-2020)
Table 50. Europe Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 51. Europe Osimertinib Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Osimertinib Sales by Region (2015-2020) (K Pcs)
Table 53. Asia Pacific Osimertinib Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Osimertinib Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Osimertinib Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 57. Asia Pacific Osimertinib Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 59. Asia Pacific Osimertinib Sales Market Share by Application (2015-2020)
Table 60. Latin America Osimertinib Sales by Country (2015-2020) (K Pcs)
Table 61. Latin America Osimertinib Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Osimertinib Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Osimertinib Revenue Market Share by Country (2015-2020)
Table 64. Latin America Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 65. Latin America Osimertinib Sales Market Share by Type (2015-2020)
Table 66. Latin America Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 67. Latin America Osimertinib Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Osimertinib Sales by Country (2015-2020) (K Pcs)
Table 69. Middle East and Africa Osimertinib Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Osimertinib Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Osimertinib Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 73. Middle East and Africa Osimertinib Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 75. Middle East and Africa Osimertinib Sales Market Share by Application (2015-2020)
Table 76. AstraZeneca Corporation Information
Table 77. AstraZeneca Description and Major Businesses
Table 78. AstraZeneca Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. AstraZeneca Product
Table 80. AstraZeneca Recent Development
Table 81. Incepta Pharmaceuticals Limited Corporation Information
Table 82. Incepta Pharmaceuticals Limited Description and Major Businesses
Table 83. Incepta Pharmaceuticals Limited Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Incepta Pharmaceuticals Limited Product
Table 85. Incepta Pharmaceuticals Limited Recent Development
Table 86. Everest Pharmaceuticals Corporation Information
Table 87. Everest Pharmaceuticals Description and Major Businesses
Table 88. Everest Pharmaceuticals Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Everest Pharmaceuticals Product
Table 90. Everest Pharmaceuticals Recent Development
Table 91. Beacon Pharma Corporation Information
Table 92. Beacon Pharma Description and Major Businesses
Table 93. Beacon Pharma Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Beacon Pharma Product
Table 95. Beacon Pharma Recent Development
Table 96. Drug International Corporation Information
Table 97. Drug International Description and Major Businesses
Table 98. Drug International Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Drug International Product
Table 100. Drug International Recent Development
Table 101. Global Osimertinib Sales Forecast by Regions (2021-2026) (K Pcs)
Table 102. Global Osimertinib Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Osimertinib Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Osimertinib Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Osimertinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 106. North America: Osimertinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Osimertinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Europe: Osimertinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Osimertinib Sales Forecast by Region (2021-2026) (K Pcs)
Table 110. Asia Pacific: Osimertinib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Osimertinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. Latin America: Osimertinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Osimertinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Middle East and Africa: Osimertinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Osimertinib Players
Table 119. Osimertinib Customers List
Table 120. Osimertinib Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 1. Osimertinib Market Segments
Table 2. Ranking of Global Top Osimertinib Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Osimertinib Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of 40mg*30 Tablets
Table 5. Major Manufacturers of 80mg*30 Tablets
Table 6. Major Manufacturers of 40mg*10 Tablets
Table 7. Major Manufacturers of 80mg*10 Tablets
Table 8. COVID-19 Impact Global Market: (Four Osimertinib Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Osimertinib Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Osimertinib Players to Combat Covid-19 Impact
Table 13. Global Osimertinib Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 14. Global Osimertinib Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 15. Global Osimertinib Sales by Regions 2015-2020 (K Pcs)
Table 16. Global Osimertinib Sales Market Share by Regions (2015-2020)
Table 17. Global Osimertinib Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Osimertinib Sales by Manufacturers (2015-2020) (K Pcs)
Table 19. Global Osimertinib Sales Share by Manufacturers (2015-2020)
Table 20. Global Osimertinib Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Osimertinib by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osimertinib as of 2019)
Table 22. Osimertinib Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Osimertinib Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Osimertinib Price (2015-2020) (USD/Pcs)
Table 25. Osimertinib Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Osimertinib Product Type
Table 27. Date of International Manufacturers Enter into Osimertinib Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 30. Global Osimertinib Sales Share by Type (2015-2020)
Table 31. Global Osimertinib Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Osimertinib Revenue Share by Type (2015-2020)
Table 33. Osimertinib Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 34. Global Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 35. Global Osimertinib Sales Share by Application (2015-2020)
Table 36. North America Osimertinib Sales by Country (2015-2020) (K Pcs)
Table 37. North America Osimertinib Sales Market Share by Country (2015-2020)
Table 38. North America Osimertinib Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Osimertinib Revenue Market Share by Country (2015-2020)
Table 40. North America Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 41. North America Osimertinib Sales Market Share by Type (2015-2020)
Table 42. North America Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 43. North America Osimertinib Sales Market Share by Application (2015-2020)
Table 44. Europe Osimertinib Sales by Country (2015-2020) (K Pcs)
Table 45. Europe Osimertinib Sales Market Share by Country (2015-2020)
Table 46. Europe Osimertinib Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Osimertinib Revenue Market Share by Country (2015-2020)
Table 48. Europe Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 49. Europe Osimertinib Sales Market Share by Type (2015-2020)
Table 50. Europe Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 51. Europe Osimertinib Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Osimertinib Sales by Region (2015-2020) (K Pcs)
Table 53. Asia Pacific Osimertinib Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Osimertinib Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Osimertinib Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 57. Asia Pacific Osimertinib Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 59. Asia Pacific Osimertinib Sales Market Share by Application (2015-2020)
Table 60. Latin America Osimertinib Sales by Country (2015-2020) (K Pcs)
Table 61. Latin America Osimertinib Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Osimertinib Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Osimertinib Revenue Market Share by Country (2015-2020)
Table 64. Latin America Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 65. Latin America Osimertinib Sales Market Share by Type (2015-2020)
Table 66. Latin America Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 67. Latin America Osimertinib Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Osimertinib Sales by Country (2015-2020) (K Pcs)
Table 69. Middle East and Africa Osimertinib Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Osimertinib Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Osimertinib Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Osimertinib Sales by Type (2015-2020) (K Pcs)
Table 73. Middle East and Africa Osimertinib Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Osimertinib Sales by Application (2015-2020) (K Pcs)
Table 75. Middle East and Africa Osimertinib Sales Market Share by Application (2015-2020)
Table 76. AstraZeneca Corporation Information
Table 77. AstraZeneca Description and Major Businesses
Table 78. AstraZeneca Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. AstraZeneca Product
Table 80. AstraZeneca Recent Development
Table 81. Incepta Pharmaceuticals Limited Corporation Information
Table 82. Incepta Pharmaceuticals Limited Description and Major Businesses
Table 83. Incepta Pharmaceuticals Limited Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Incepta Pharmaceuticals Limited Product
Table 85. Incepta Pharmaceuticals Limited Recent Development
Table 86. Everest Pharmaceuticals Corporation Information
Table 87. Everest Pharmaceuticals Description and Major Businesses
Table 88. Everest Pharmaceuticals Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Everest Pharmaceuticals Product
Table 90. Everest Pharmaceuticals Recent Development
Table 91. Beacon Pharma Corporation Information
Table 92. Beacon Pharma Description and Major Businesses
Table 93. Beacon Pharma Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Beacon Pharma Product
Table 95. Beacon Pharma Recent Development
Table 96. Drug International Corporation Information
Table 97. Drug International Description and Major Businesses
Table 98. Drug International Osimertinib Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Drug International Product
Table 100. Drug International Recent Development
Table 101. Global Osimertinib Sales Forecast by Regions (2021-2026) (K Pcs)
Table 102. Global Osimertinib Sales Market Share Forecast by Regions (2021-2026)
Table 103. Global Osimertinib Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 104. Global Osimertinib Revenue Market Share Forecast by Regions (2021-2026)
Table 105. North America: Osimertinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 106. North America: Osimertinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Europe: Osimertinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Europe: Osimertinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Asia Pacific: Osimertinib Sales Forecast by Region (2021-2026) (K Pcs)
Table 110. Asia Pacific: Osimertinib Revenue Forecast by Region (2021-2026) (US$ Million)
Table 111. Latin America: Osimertinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. Latin America: Osimertinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Middle East and Africa: Osimertinib Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Middle East and Africa: Osimertinib Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 116. Key Challenges
Table 117. Market Risks
Table 118. Main Points Interviewed from Key Osimertinib Players
Table 119. Osimertinib Customers List
Table 120. Osimertinib Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Osimertinib Product Picture
Figure 2. Global Osimertinib Sales Market Share by Type in 2020 & 2026
Figure 3. 40mg*30 Tablets Product Picture
Figure 4. 80mg*30 Tablets Product Picture
Figure 5. 40mg*10 Tablets Product Picture
Figure 6. 80mg*10 Tablets Product Picture
Figure 7. Global Osimertinib Sales Market Share by Application in 2020 & 2026
Figure 8. Locally Advanced NSCLC
Figure 9. Metastatic NSCLC
Figure 10. Other
Figure 11. Osimertinib Report Years Considered
Figure 12. Global Osimertinib Market Size 2015-2026 (US$ Million)
Figure 13. Global Osimertinib Sales 2015-2026 (K Pcs)
Figure 14. Global Osimertinib Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Osimertinib Sales Market Share by Region (2015-2020)
Figure 16. Global Osimertinib Sales Market Share by Region in 2019
Figure 17. Global Osimertinib Revenue Market Share by Region (2015-2020)
Figure 18. Global Osimertinib Revenue Market Share by Region in 2019
Figure 19. Global Osimertinib Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Osimertinib Revenue in 2019
Figure 21. Osimertinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Osimertinib Sales Market Share by Type (2015-2020)
Figure 23. Global Osimertinib Sales Market Share by Type in 2019
Figure 24. Global Osimertinib Revenue Market Share by Type (2015-2020)
Figure 25. Global Osimertinib Revenue Market Share by Type in 2019
Figure 26. Global Osimertinib Market Share by Price Range (2015-2020)
Figure 27. Global Osimertinib Sales Market Share by Application (2015-2020)
Figure 28. Global Osimertinib Sales Market Share by Application in 2019
Figure 29. Global Osimertinib Revenue Market Share by Application (2015-2020)
Figure 30. Global Osimertinib Revenue Market Share by Application in 2019
Figure 31. North America Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Osimertinib Sales Market Share by Country in 2019
Figure 34. North America Osimertinib Revenue Market Share by Country in 2019
Figure 35. U.S. Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Osimertinib Market Share by Type in 2019
Figure 40. North America Osimertinib Market Share by Application in 2019
Figure 41. Europe Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Osimertinib Sales Market Share by Country in 2019
Figure 44. Europe Osimertinib Revenue Market Share by Country in 2019
Figure 45. Germany Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Osimertinib Market Share by Type in 2019
Figure 56. Europe Osimertinib Market Share by Application in 2019
Figure 57. Asia Pacific Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Osimertinib Sales Market Share by Region in 2019
Figure 60. Asia Pacific Osimertinib Revenue Market Share by Region in 2019
Figure 61. China Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Osimertinib Market Share by Type in 2019
Figure 84. Asia Pacific Osimertinib Market Share by Application in 2019
Figure 85. Latin America Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Osimertinib Sales Market Share by Country in 2019
Figure 88. Latin America Osimertinib Revenue Market Share by Country in 2019
Figure 89. Mexico Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Osimertinib Market Share by Type in 2019
Figure 96. Latin America Osimertinib Market Share by Application in 2019
Figure 97. Middle East and Africa Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Osimertinib Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Osimertinib Revenue Market Share by Country in 2019
Figure 101. Turkey Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Osimertinib Market Share by Type in 2019
Figure 108. Middle East and Africa Osimertinib Market Share by Application in 2019
Figure 109. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Incepta Pharmaceuticals Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Everest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Beacon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Drug International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. North America Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Europe Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Asia Pacific Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Latin America Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Middle East and Africa Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
Figure 1. Osimertinib Product Picture
Figure 2. Global Osimertinib Sales Market Share by Type in 2020 & 2026
Figure 3. 40mg*30 Tablets Product Picture
Figure 4. 80mg*30 Tablets Product Picture
Figure 5. 40mg*10 Tablets Product Picture
Figure 6. 80mg*10 Tablets Product Picture
Figure 7. Global Osimertinib Sales Market Share by Application in 2020 & 2026
Figure 8. Locally Advanced NSCLC
Figure 9. Metastatic NSCLC
Figure 10. Other
Figure 11. Osimertinib Report Years Considered
Figure 12. Global Osimertinib Market Size 2015-2026 (US$ Million)
Figure 13. Global Osimertinib Sales 2015-2026 (K Pcs)
Figure 14. Global Osimertinib Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Osimertinib Sales Market Share by Region (2015-2020)
Figure 16. Global Osimertinib Sales Market Share by Region in 2019
Figure 17. Global Osimertinib Revenue Market Share by Region (2015-2020)
Figure 18. Global Osimertinib Revenue Market Share by Region in 2019
Figure 19. Global Osimertinib Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Osimertinib Revenue in 2019
Figure 21. Osimertinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Osimertinib Sales Market Share by Type (2015-2020)
Figure 23. Global Osimertinib Sales Market Share by Type in 2019
Figure 24. Global Osimertinib Revenue Market Share by Type (2015-2020)
Figure 25. Global Osimertinib Revenue Market Share by Type in 2019
Figure 26. Global Osimertinib Market Share by Price Range (2015-2020)
Figure 27. Global Osimertinib Sales Market Share by Application (2015-2020)
Figure 28. Global Osimertinib Sales Market Share by Application in 2019
Figure 29. Global Osimertinib Revenue Market Share by Application (2015-2020)
Figure 30. Global Osimertinib Revenue Market Share by Application in 2019
Figure 31. North America Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Osimertinib Sales Market Share by Country in 2019
Figure 34. North America Osimertinib Revenue Market Share by Country in 2019
Figure 35. U.S. Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Osimertinib Market Share by Type in 2019
Figure 40. North America Osimertinib Market Share by Application in 2019
Figure 41. Europe Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Osimertinib Sales Market Share by Country in 2019
Figure 44. Europe Osimertinib Revenue Market Share by Country in 2019
Figure 45. Germany Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Osimertinib Market Share by Type in 2019
Figure 56. Europe Osimertinib Market Share by Application in 2019
Figure 57. Asia Pacific Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Osimertinib Sales Market Share by Region in 2019
Figure 60. Asia Pacific Osimertinib Revenue Market Share by Region in 2019
Figure 61. China Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Osimertinib Market Share by Type in 2019
Figure 84. Asia Pacific Osimertinib Market Share by Application in 2019
Figure 85. Latin America Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Osimertinib Sales Market Share by Country in 2019
Figure 88. Latin America Osimertinib Revenue Market Share by Country in 2019
Figure 89. Mexico Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Osimertinib Market Share by Type in 2019
Figure 96. Latin America Osimertinib Market Share by Application in 2019
Figure 97. Middle East and Africa Osimertinib Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Osimertinib Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Osimertinib Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Osimertinib Revenue Market Share by Country in 2019
Figure 101. Turkey Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Osimertinib Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Osimertinib Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Osimertinib Market Share by Type in 2019
Figure 108. Middle East and Africa Osimertinib Market Share by Application in 2019
Figure 109. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Incepta Pharmaceuticals Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Everest Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Beacon Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Drug International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. North America Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Europe Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Asia Pacific Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Latin America Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Osimertinib Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Middle East and Africa Osimertinib Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed